LPA and hyperlipidemia: Finally, our study pinpointed LPC and LPA as key downstream metabolites and established the ACSL1‐LPC‐ATX‐LPA axis as an intricate metabolic pathway that aggravates thromboinflammation in AMI due to hyperlipidemia.